Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000897069-20-000054
Filing Date
2020-01-27
Accepted
2020-01-27 14:45:58
Documents
1
Effectiveness Date
2020-01-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5833
  Complete submission text file 0000897069-20-000054.txt   7034
Mailing Address 19 MORRIS AVENUE BROOKLYN NAVY YARD, BUILDING 128 BROOKLYN NY 11205
Business Address 19 MORRIS AVENUE BROOKLYN NAVY YARD, BUILDING 128 BROOKLYN NY 11205 (516) 962-3186
Cambrian BioPharma Inc (Filer) CIK: 0001797409 (see all company filings)

EIN.: 842985609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-359008 | Film No.: 20549026